{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,3]],"date-time":"2026-02-03T00:54:03Z","timestamp":1770080043263,"version":"3.49.0"},"reference-count":64,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,3,19]],"date-time":"2025-03-19T00:00:00Z","timestamp":1742342400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,3,19]],"date-time":"2025-03-19T00:00:00Z","timestamp":1742342400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82305179"],"award-info":[{"award-number":["82305179"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82374292"],"award-info":[{"award-number":["82374292"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002858","name":"China Postdoctoral Science Foundation","doi-asserted-by":"publisher","award":["2022M720520"],"award-info":[{"award-number":["2022M720520"]}],"id":[{"id":"10.13039\/501100002858","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Transl Med"],"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:sec>\n            <jats:title>Background<\/jats:title>\n            <jats:p>Gastric cancer, recognized as one of the most lethal malignancies globally, progresses through a complex, multi-stage development. Elucidating the pathogenic mechanisms behind gastric carcinogenesis and identifying early diagnostic biomarkers are pivotal for decreasing the prevalence of gastric cancer.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods<\/jats:title>\n            <jats:p>Using datasets on gastric cancer and its transformation from gastritis, we employed machine learning to create an early diagnostic model, identifying key genes and evaluating accuracy. We prioritized genes in the gastritis-to-cancer progression, identifying a central driver gene. Pathway analysis revealed its transformation role. Tissue microarrays and rat models validated the driver genes and networks, confirmed in cell and organoid models. We also identified cell types secreting CHI3L1 using single-cell RNA sequencing and multiplex immunohistochemistry, exploring their prognostic significance.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results<\/jats:title>\n            <jats:p>We identified 12 driver genes potentially involved in the gastritis-to-cancer transformation, with CHI3L1, MMP12, CXCL6, IDO1, and CCL20 emerging as the top five genes via a early gastric cancer diagnostic model. CHI3L1 was pinpointed as the central driver across the gastritis-to-cancer spectrum, with its upregulation, along with CD44, \u03b2-catenin, and c-Myc, noted in gastric precancerous lesions. In vitro and organoid studies revealed CHI3L1\u2019s role in activating the CD44-\u03b2-catenin pathway to induce malignancy. Furthermore, our findings indicate that fibroblasts and dendritic cells are the principal sources of CHI3L1 secretion, a factor that is associated with poor prognosis in gastric cancer.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusions<\/jats:title>\n            <jats:p>This study highlights CHI3L1 as a key gene driving the progression from gastritis to gastric cancer, primarily by activating the CD44-\u03b2-catenin pathway, which enhances malignant cell traits. CHI3L1 is mainly secreted by fibroblasts and dendritic cells, and its high levels are linked to poor gastric cancer prognosis.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1186\/s12967-025-06352-2","type":"journal-article","created":{"date-parts":[[2025,3,19]],"date-time":"2025-03-19T10:35:41Z","timestamp":1742380541000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["CHI3L1: a key driver in gastritis-to-cancer transformation"],"prefix":"10.1186","volume":"23","author":[{"given":"Tao","family":"Li","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Huizhong","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yucheng","family":"Gong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mengting","family":"Liao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuanping","family":"Jia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jiena","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ming","family":"Dai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yinan","family":"Yan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xinyu","family":"Lu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Runhua","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuan","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yan","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jie","family":"Lin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yicong","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7346-942X","authenticated-orcid":false,"given":"Xia","family":"Ding","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,3,19]]},"reference":[{"key":"6352_CR1","first-page":"6735","volume":"52","author":"P Correa","year":"1992","unstructured":"Correa P. Human gastric carcinogenesis: A multistep and multifactorial process\u2013First American Cancer society award lecture on Cancer epidemiology and prevention. Cancer Res. 1992;52:6735\u201340.","journal-title":"Cancer Res"},{"key":"6352_CR2","doi-asserted-by":"publisher","first-page":"635","DOI":"10.1016\/S0140-6736(20)31288-5","volume":"396","author":"EC Smyth","year":"2020","unstructured":"Smyth EC, Nilsson M, Grabsch HI, van Grieken. NC and Lordick F. Gastric cancer. Lancet. 2020;396:635\u201348.","journal-title":"Lancet"},{"key":"6352_CR3","doi-asserted-by":"publisher","first-page":"338","DOI":"10.1038\/s41571-023-00747-0","volume":"20","author":"AP Thrift","year":"2023","unstructured":"Thrift AP, Wenker TN, El-Serag HB. Global burden of gastric cancer: epidemiological trends, risk factors, screening and prevention. Nat Rev Clin Oncol. 2023;20:338\u201349.","journal-title":"Nat Rev Clin Oncol"},{"key":"6352_CR4","doi-asserted-by":"publisher","first-page":"6412","DOI":"10.3748\/wjg.v20.i21.6412","volume":"20","author":"I Lee","year":"2014","unstructured":"Lee I. Critical pathogenic steps to high risk Helicobacter pylori gastritis and gastric carcinogenesis. World J Gastroenterol. 2014;20:6412\u20139.","journal-title":"World J Gastroenterol"},{"key":"6352_CR5","doi-asserted-by":"publisher","first-page":"6857","DOI":"10.2147\/JIR.S390448","volume":"15","author":"R Jia","year":"2022","unstructured":"Jia R, Guo X, Liu H, Zhao F, Fan Z, Wang M, et al. Analysis of staged features of Gastritis-Cancer transformation and identification of potential biomarkers in gastric cancer. J Inflamm Res. 2022;15:6857\u201368.","journal-title":"J Inflamm Res"},{"key":"6352_CR6","doi-asserted-by":"publisher","first-page":"316","DOI":"10.1016\/j.tim.2016.12.004","volume":"25","author":"M Naumann","year":"2017","unstructured":"Naumann M, Sokolova O, Tegtmeyer N, Backert S. Helicobacter pylori: A paradigm pathogen for subverting host cell signal transmission. Trends Microbiol. 2017;25:316\u201328.","journal-title":"Trends Microbiol"},{"key":"6352_CR7","doi-asserted-by":"publisher","first-page":"3861","DOI":"10.1113\/JP275512","volume":"596","author":"AR Meyer","year":"2018","unstructured":"Meyer AR, Goldenring JR. Injury, repair, inflammation and metaplasia in the stomach. J Physiol. 2018;596:3861\u20137.","journal-title":"J Physiol"},{"key":"6352_CR8","doi-asserted-by":"publisher","first-page":"84","DOI":"10.61186\/ijbc.16.2.84","volume":"16","author":"SA Aghapour","year":"2024","unstructured":"Aghapour SA, Torabizadeh M, Bahreiny SS, Saki N, Far MAJ, Yousefi-Avarvand A, et al. Investigating the dynamic interplay between cellular immunity and tumor cells in the fight against cancer: an updated comprehensive review. IJBC. 2024;16:84\u2013101.","journal-title":"IJBC"},{"key":"6352_CR9","doi-asserted-by":"publisher","first-page":"901","DOI":"10.1016\/j.trecan.2022.07.002","volume":"8","author":"D Denk","year":"2022","unstructured":"Denk D, Greten FR, Inflammation. The incubator of the tumor microenvironment. Trends Cancer. 2022;8:901\u201314.","journal-title":"Trends Cancer"},{"key":"6352_CR10","doi-asserted-by":"publisher","first-page":"166","DOI":"10.32074\/1591-951X-166","volume":"112","author":"I Gullo","year":"2020","unstructured":"Gullo I, Grillo F, Mastracci L, Vanoli A, Carneiro F, Saragoni L, et al. Precancerous lesions of the stomach, gastric cancer and hereditary gastric cancer syndromes. Pathologica. 2020;112:166\u201385.","journal-title":"Pathologica"},{"key":"6352_CR11","doi-asserted-by":"publisher","first-page":"1067","DOI":"10.1053\/j.gastro.2021.12.252","volume":"162","author":"D Liabeuf","year":"2022","unstructured":"Liabeuf D, Oshima M, Stange DE, Sigal M. Stem cells, helicobacter pylori, and mutational landscape: utility of preclinical models to understand carcinogenesis and to direct management of gastric cancer. Gastroenterology. 2022;162:1067\u201387.","journal-title":"Gastroenterology"},{"key":"6352_CR12","doi-asserted-by":"publisher","first-page":"512","DOI":"10.1089\/gtmb.2022.0094","volume":"26","author":"M Wang","year":"2022","unstructured":"Wang M, Jiang X, Xu S, Deng Y, Cao T, Cheng Y, et al. Identifying diagnostic and prognostic differentially expressed genes of gastric cancer based on bioinformatics analyses of RNA-seq data. Genet Test Mol Biomarkers. 2022;26:512\u201321.","journal-title":"Genet Test Mol Biomarkers"},{"key":"6352_CR13","doi-asserted-by":"publisher","first-page":"6218","DOI":"10.1002\/jcp.29550","volume":"235","author":"S Deng","year":"2020","unstructured":"Deng S, Zhang X, Qin Y, Chen W, Fan H, Feng X, et al. MiRNA-192 and\u2013\u2009215 activate Wnt\/beta-catenin signaling pathway in gastric cancer via APC. J Cell Physiol. 2020;235:6218\u201329.","journal-title":"J Cell Physiol"},{"key":"6352_CR14","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1016\/j.omto.2020.03.020","volume":"17","author":"L Min","year":"2020","unstructured":"Min L, Zhu S, Wei R, Zhao Y, Liu S, Li P, et al. Integrating SWATH-MS proteomics and transcriptome analysis identifies CHI3L1 as a plasma biomarker for early gastric cancer. Mol Ther Oncolytics. 2020;17:257\u201366.","journal-title":"Mol Ther Oncolytics"},{"key":"6352_CR15","doi-asserted-by":"publisher","first-page":"17883","DOI":"10.3748\/wjg.v20.i47.17883","volume":"20","author":"X Xu","year":"2014","unstructured":"Xu X, Feng L, Liu Y, Zhou WX, Ma YC, Fei GJ, et al. Differential gene expression profiling of gastric intraepithelial neoplasia and early-stage adenocarcinoma. World J Gastroenterol. 2014;20:17883\u201393.","journal-title":"World J Gastroenterol"},{"key":"6352_CR16","doi-asserted-by":"publisher","first-page":"1777","DOI":"10.1038\/s41467-018-04179-8","volume":"9","author":"SC Oh","year":"2018","unstructured":"Oh SC, Sohn BH, Cheong JH, Kim SB, Lee JE, Park KC, et al. Clinical and genomic landscape of gastric cancer with a mesenchymal phenotype. Nat Commun. 2018;9:1777.","journal-title":"Nat Commun"},{"key":"6352_CR17","doi-asserted-by":"publisher","first-page":"6099","DOI":"10.2147\/OTT.S110203","volume":"9","author":"J He","year":"2016","unstructured":"He J, Jin Y, Chen Y, Yao HB, Xia YJ, Ma YY, et al. Downregulation of ALDOB is associated with poor prognosis of patients with gastric cancer. Onco Targets Ther. 2016;9:6099\u2013109.","journal-title":"Onco Targets Ther"},{"key":"6352_CR18","doi-asserted-by":"publisher","first-page":"e47","DOI":"10.1093\/nar\/gkv007","volume":"43","author":"ME Ritchie","year":"2015","unstructured":"Ritchie ME, Phipson B, Wu D, Hu Y, Law CW, Shi W, et al. Limma powers differential expression analyses for RNA-sequencing and microarray studies. Nucleic Acids Res. 2015;43:e47.","journal-title":"Nucleic Acids Res"},{"key":"6352_CR19","doi-asserted-by":"publisher","first-page":"927731","DOI":"10.3389\/fphar.2022.927731","volume":"13","author":"Y Li","year":"2022","unstructured":"Li Y, Li T, Chen J, Zheng H, Li Y, Chu F, et al. Manpixiao Decoction halted the malignant transformation of precancerous lesions of gastric cancer: from network prediction to In-Vivo verification. Front Pharmacol. 2022;13:927731.","journal-title":"Front Pharmacol"},{"key":"6352_CR20","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1186\/1471-2105-9-559","volume":"9","author":"P Langfelder","year":"2008","unstructured":"Langfelder P, Horvath SWGCNA. An R package for weighted correlation network analysis. BMC Bioinformatics. 2008;9:559.","journal-title":"BMC Bioinformatics"},{"key":"6352_CR21","first-page":"100141","volume":"2","author":"T Wu","year":"2021","unstructured":"Wu T, Hu E, Xu S, Chen M, Guo P, Dai Z, et al. ClusterProfiler 4.0: A universal enrichment tool for interpreting omics data. Innov (Camb). 2021;2:100141.","journal-title":"Innov (Camb)"},{"key":"6352_CR22","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1023\/A:1010933404324","volume":"45","author":"L Breiman","year":"2001","unstructured":"Breiman L. Random forests. Mach Learn. 2001;45:5\u201332.","journal-title":"Mach Learn"},{"key":"6352_CR23","doi-asserted-by":"publisher","first-page":"754","DOI":"10.1016\/j.ajodo.2023.08.003","volume":"164","author":"D Valkenborg","year":"2023","unstructured":"Valkenborg D, Rousseau AJ, Geubbelmans M, Burzykowski T. Support vector machines. Am J Orthod Dentofac Orthop. 2023;164:754\u20137.","journal-title":"Am J Orthod Dentofac Orthop"},{"key":"6352_CR24","doi-asserted-by":"crossref","unstructured":"Chen T, Guestrin C, XGBoost. A scalable tree boosting system. KDD \u201816: Proceedings of the 22nd ACM SIGKDD International Conference on Knowledge Discovery and Data Mining, New York, NY, USA: ACM; 2016, pp. 785\u2013794.","DOI":"10.1145\/2939672.2939785"},{"key":"6352_CR25","doi-asserted-by":"publisher","first-page":"370","DOI":"10.2307\/2344614","volume":"135","author":"JA Nelder","year":"1972","unstructured":"Nelder JA, Wedderburn RWM. Generalized linear models. J Royal Stat Soc Ser (General). 1972;135:370\u201384.","journal-title":"J Royal Stat Soc Ser (General)"},{"key":"6352_CR26","unstructured":"Biecek P. DALEX: explainers for complex predictive models in R. J Mach Learn Res2018, pp. 1\u20135."},{"key":"6352_CR27","doi-asserted-by":"publisher","first-page":"15545","DOI":"10.1073\/pnas.0506580102","volume":"102","author":"A Subramanian","year":"2005","unstructured":"Subramanian A, Tamayo P, Mootha VK, Mukherjee S, Ebert BL, Gillette MA, et al. Gene set enrichment analysis: A knowledge-based approach for interpreting genome-wide expression profiles. Proc Natl Acad Sci U S A. 2005;102:15545\u201350.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"6352_CR28","first-page":"100625","volume":"5","author":"B Gyorffy","year":"2024","unstructured":"Gyorffy B. Integrated analysis of public datasets for the discovery and validation of survival-associated genes in solid tumors. Innov (Camb). 2024;5:100625.","journal-title":"Innov (Camb)"},{"key":"6352_CR29","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1186\/s40537-023-00844-y","volume":"10","author":"Z Liu","year":"2023","unstructured":"Liu Z, Liu L, Weng S, Xu H, Xing Z, Ren Y, et al. BEST: A web application for comprehensive biomarker exploration on large-scale data in solid tumors. J Big Data. 2023;10:165.","journal-title":"J Big Data"},{"key":"6352_CR30","doi-asserted-by":"publisher","first-page":"6529","DOI":"10.1158\/1078-0432.CCR-21-0792","volume":"27","author":"HY Jeong","year":"2021","unstructured":"Jeong HY, Ham IH, Lee SH, Ryu D, Son SY, Han SU, et al. Spatially distinct reprogramming of the tumor microenvironment based on tumor invasion in Diffuse-Type gastric cancers. Clin Cancer Res. 2021;27:6529\u201342.","journal-title":"Clin Cancer Res"},{"key":"6352_CR31","doi-asserted-by":"publisher","first-page":"D1407","DOI":"10.1093\/nar\/gkad753","volume":"52","author":"Y Deng","year":"2024","unstructured":"Deng Y, Chen P, Xiao J, Li M, Shen J, Qin S, et al. SCAR: Single-cell and spatially-resolved cancer resources. Nucleic Acids Res. 2024;52:D1407\u201317.","journal-title":"Nucleic Acids Res"},{"key":"6352_CR32","doi-asserted-by":"publisher","first-page":"3573","DOI":"10.1016\/j.cell.2021.04.048","volume":"184","author":"Y Hao","year":"2021","unstructured":"Hao Y, Hao S, Andersen-Nissen E, Mauck WR, Zheng S, Butler A, et al. Integrated analysis of multimodal single-cell data. Cell. 2021;184:3573\u201387.","journal-title":"Cell"},{"key":"6352_CR33","doi-asserted-by":"publisher","first-page":"733979","DOI":"10.3389\/fphys.2021.733979","volume":"12","author":"F Chu","year":"2021","unstructured":"Chu F, Li Y, Meng X, Li Y, Li T, Zhai M, et al. Gut microbial dysbiosis and changes in fecal metabolic phenotype in precancerous lesions of gastric cancer induced with N-Methyl-N\u2019-Nitro-N-Nitrosoguanidine, sodium salicylate, ranitidine, and irregular diet. Front Physiol. 2021;12:733979.","journal-title":"Front Physiol"},{"key":"6352_CR34","doi-asserted-by":"publisher","first-page":"114399","DOI":"10.1016\/j.jep.2021.114399","volume":"279","author":"Y Wang","year":"2021","unstructured":"Wang Y, Chu F, Lin J, Li Y, Johnson N, Zhang J, et al. Erianin, the main active ingredient of Dendrobium chrysotoxum Lindl, inhibits precancerous lesions of gastric cancer (PLGC) through suppression of the HRAS-PI3K-AKT signaling pathway as revealed by network Pharmacology and in vitro experimental verification. J Ethnopharmacol. 2021;279:114399.","journal-title":"J Ethnopharmacol"},{"key":"6352_CR35","doi-asserted-by":"publisher","first-page":"208","DOI":"10.1186\/s13046-018-0876-2","volume":"37","author":"B Geng","year":"2018","unstructured":"Geng B, Pan J, Zhao T, Ji J, Zhang C, Che Y, et al. Chitinase 3-like 1-CD44 interaction promotes metastasis and epithelial-to-mesenchymal transition through beta-catenin\/Erk\/Akt signaling in gastric cancer. J Exp Clin Cancer Res. 2018;37:208.","journal-title":"J Exp Clin Cancer Res"},{"key":"6352_CR36","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1053\/j.gastro.2014.09.042","volume":"148","author":"S Bartfeld","year":"2015","unstructured":"Bartfeld S, Bayram T, van de Wetering M, Huch M, Begthel H, Kujala P, et al. In vitro expansion of human gastric epithelial stem cells and their responses to bacterial infection. Gastroenterology. 2015;148:126\u201336.","journal-title":"Gastroenterology"},{"key":"6352_CR37","doi-asserted-by":"publisher","first-page":"1106","DOI":"10.1053\/j.gastro.2020.11.017","volume":"160","author":"MB Piazuelo","year":"2021","unstructured":"Piazuelo MB, Bravo LE, Mera RM, Camargo MC, Bravo JC, Delgado AG, et al. The Colombian chemoprevention trial: 20-Year Follow-Up of a cohort of patients with gastric precancerous lesions. Gastroenterology. 2021;160:1106\u201317.","journal-title":"Gastroenterology"},{"key":"6352_CR38","doi-asserted-by":"publisher","first-page":"1259","DOI":"10.1016\/j.cgh.2021.10.032","volume":"20","author":"S Xiao","year":"2022","unstructured":"Xiao S, Lu H, Xue Y, Cui R, Meng L, Jin Z, et al. Long-Term outcome of gastric Mild-Moderate dysplasia: A Real-World clinical experience. Clin Gastroenterol Hepatol. 2022;20:1259\u201368.","journal-title":"Clin Gastroenterol Hepatol"},{"key":"6352_CR39","doi-asserted-by":"publisher","first-page":"e2114186","DOI":"10.1001\/jamanetworkopen.2021.14186","volume":"4","author":"S Huang","year":"2021","unstructured":"Huang S, Guo Y, Li ZW, Shui G, Tian H, Li BW, et al. Identification and validation of plasma metabolomic signatures in precancerous gastric lesions that progress to cancer. JAMA Netw Open. 2021;4:e2114186.","journal-title":"JAMA Netw Open"},{"key":"6352_CR40","doi-asserted-by":"publisher","first-page":"196","DOI":"10.1016\/j.canlet.2013.08.016","volume":"345","author":"F Wang","year":"2014","unstructured":"Wang F, Meng W, Wang B, Qiao L. Helicobacter pylori-induced gastric inflammation and gastric cancer. Cancer Lett. 2014;345:196\u2013202.","journal-title":"Cancer Lett"},{"key":"6352_CR41","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1016\/S1470-2045(00)00225-4","volume":"2","author":"N Yamaguchi","year":"2001","unstructured":"Yamaguchi N, Kakizoe T. Synergistic interaction between Helicobacter pylori gastritis and diet in gastric cancer. Lancet Oncol. 2001;2:88\u201394.","journal-title":"Lancet Oncol"},{"key":"6352_CR42","doi-asserted-by":"publisher","first-page":"736","DOI":"10.1053\/j.gastro.2023.01.018","volume":"164","author":"RJ Huang","year":"2023","unstructured":"Huang RJ, Laszkowska M, In H, Hwang JH, Epplein M. Controlling gastric cancer in a world of heterogeneous risk. Gastroenterology. 2023;164:736\u201351.","journal-title":"Gastroenterology"},{"key":"6352_CR43","doi-asserted-by":"crossref","unstructured":"Vasconcelos AC, Dinis-Ribeiro M, Libanio D. Endoscopic resection of early gastric cancer and Pre-Malignant gastric lesions. Cancers (Basel) 2023; 15.","DOI":"10.3390\/cancers15123084"},{"key":"6352_CR44","doi-asserted-by":"publisher","first-page":"1934","DOI":"10.1016\/j.celrep.2019.04.052","volume":"27","author":"P Zhang","year":"2019","unstructured":"Zhang P, Yang M, Zhang Y, Xiao S, Lai X, Tan A, et al. Dissecting the Single-Cell transcriptome network underlying gastric premalignant lesions and early gastric cancer. Cell Rep. 2019;27:1934\u201347.","journal-title":"Cell Rep"},{"key":"6352_CR45","doi-asserted-by":"publisher","first-page":"103714","DOI":"10.1016\/j.ebiom.2021.103714","volume":"74","author":"X Li","year":"2021","unstructured":"Li X, Zheng NR, Wang LH, Li ZW, Liu ZC, Fan H, et al. Proteomic profiling identifies signatures associated with progression of precancerous gastric lesions and risk of early gastric cancer. Ebiomedicine. 2021;74:103714.","journal-title":"Ebiomedicine"},{"key":"6352_CR46","doi-asserted-by":"publisher","first-page":"479","DOI":"10.1146\/annurev-physiol-012110-142250","volume":"73","author":"CG Lee","year":"2011","unstructured":"Lee CG, Da SC, Dela CC, Ahangari F, Ma B, Kang MJ, et al. Role of Chitin and Chitinase\/chitinase-like proteins in inflammation, tissue remodeling, and injury. Annu Rev Physiol. 2011;73:479\u2013501.","journal-title":"Annu Rev Physiol"},{"key":"6352_CR47","doi-asserted-by":"publisher","first-page":"1149","DOI":"10.1084\/jem.20081271","volume":"206","author":"CG Lee","year":"2009","unstructured":"Lee CG, Hartl D, Lee GR, Koller B, Matsuura H, Da SC, et al. Role of breast regression protein 39 (BRP-39)\/chitinase 3-like-1 in Th2 and IL-13-induced tissue responses and apoptosis. J Exp Med. 2009;206:1149\u201366.","journal-title":"J Exp Med"},{"key":"6352_CR48","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s12276-023-01131-9","volume":"56","author":"JE Yu","year":"2024","unstructured":"Yu JE, Yeo IJ, Han SB, Yun J, Kim B, Yong YJ, et al. Significance of chitinase-3-like protein 1 in the pathogenesis of inflammatory diseases and cancer. Exp Mol Med. 2024;56:1\u201318.","journal-title":"Exp Mol Med"},{"key":"6352_CR49","doi-asserted-by":"publisher","first-page":"107394","DOI":"10.1016\/j.pharmthera.2019.107394","volume":"203","author":"IJ Yeo","year":"2019","unstructured":"Yeo IJ, Lee CK, Han SB, Yun J, Hong JT. Roles of chitinase 3-like 1 in the development of cancer, neurodegenerative diseases, and inflammatory diseases. Pharmacol Ther. 2019;203:107394.","journal-title":"Pharmacol Ther"},{"key":"6352_CR50","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1186\/s13045-017-0408-0","volume":"10","author":"Y Chen","year":"2017","unstructured":"Chen Y, Zhang S, Wang Q, Zhang X. Tumor-recruited M2 macrophages promote gastric and breast cancer metastasis via M2 macrophage-secreted CHI3L1 protein. J Hematol Oncol. 2017;10:36.","journal-title":"J Hematol Oncol"},{"key":"6352_CR51","doi-asserted-by":"publisher","first-page":"307","DOI":"10.21873\/anticanres.16813","volume":"44","author":"T Oshima","year":"2024","unstructured":"Oshima T, Hashimoto I, Hiroshima Y, Kimura Y, Tanabe M, Onuma S, et al. Clinical significance of chitinase-3-like protein 1 gene expression in patients with locally advanced gastric cancer. Anticancer Res. 2024;44:307\u201312.","journal-title":"Anticancer Res"},{"key":"6352_CR52","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1016\/j.canlet.2015.10.037","volume":"371","author":"J Garay","year":"2016","unstructured":"Garay J, Piazuelo MB, Majumdar S, Li L, Trillo-Tinoco J, Del VL, et al. The homing receptor CD44 is involved in the progression of precancerous gastric lesions in patients infected with Helicobacter pylori and in development of mucous metaplasia in mice. Cancer Lett. 2016;371:90\u20138.","journal-title":"Cancer Lett"},{"key":"6352_CR53","doi-asserted-by":"crossref","unstructured":"Garai J, Li L, Zabaleta J. Biomarkers of gastric premalignant lesions. 2020: 81\u201388.","DOI":"10.1007\/978-3-030-29286-7_7"},{"key":"6352_CR54","doi-asserted-by":"publisher","first-page":"254","DOI":"10.1038\/nrc3023","volume":"11","author":"M Zoller","year":"2011","unstructured":"Zoller M. CD44: can a cancer-initiating cell profit from an abundantly expressed molecule? Nat Rev Cancer. 2011;11:254\u201367.","journal-title":"Nat Rev Cancer"},{"key":"6352_CR55","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1016\/j.jcmgh.2017.03.003","volume":"4","author":"Y Zavros","year":"2017","unstructured":"Zavros Y. Initiation and maintenance of gastric cancer: A focus on CD44 variant isoforms and cancer stem cells. Cell Mol Gastroenterol Hepatol. 2017;4:55\u201363.","journal-title":"Cell Mol Gastroenterol Hepatol"},{"key":"6352_CR56","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1186\/s13045-018-0605-5","volume":"11","author":"C Chen","year":"2018","unstructured":"Chen C, Zhao S, Karnad A, Freeman JW. The biology and role of CD44 in cancer progression: therapeutic implications. J Hematol Oncol. 2018;11:64.","journal-title":"J Hematol Oncol"},{"key":"6352_CR57","doi-asserted-by":"publisher","first-page":"1192","DOI":"10.1016\/j.cell.2012.05.012","volume":"149","author":"H Clevers","year":"2012","unstructured":"Clevers H, Nusse R. Wnt\/beta-catenin signaling and disease. Cell. 2012;149:1192\u2013205.","journal-title":"Cell"},{"key":"6352_CR58","doi-asserted-by":"publisher","first-page":"5497","DOI":"10.1038\/onc.2008.245","volume":"27","author":"TL Yuan","year":"2008","unstructured":"Yuan TL, Cantley LC. PI3K pathway alterations in cancer: variations on a theme. Oncogene. 2008;27:5497\u2013510.","journal-title":"Oncogene"},{"key":"6352_CR59","doi-asserted-by":"publisher","first-page":"3291","DOI":"10.1038\/sj.onc.1210422","volume":"26","author":"PJ Roberts","year":"2007","unstructured":"Roberts PJ, Der CJ. Targeting the Raf-MEK-ERK mitogen-activated protein kinase cascade for the treatment of cancer. Oncogene. 2007;26:3291\u2013310.","journal-title":"Oncogene"},{"key":"6352_CR60","doi-asserted-by":"publisher","first-page":"34351","DOI":"10.1007\/s11042-023-16971-w","volume":"83","author":"T Salehnia","year":"2024","unstructured":"Salehnia T, Seyfollahi A, Raziani S, Noori A, Ghaffari A, Alsoud AR, et al. An optimal task scheduling method in IoT-Fog-Cloud network using multi-objective moth-flame algorithm. Multimed Tools Appl. 2024;83:34351\u201372.","journal-title":"Multimed Tools Appl"},{"key":"6352_CR61","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1007\/s42235-023-00436-9","volume":"21","author":"A Got","year":"2024","unstructured":"Got A, Zouache D, Moussaoui A, Abualigah L, Alsayat A. Improved manta ray foraging optimizer-based SVM for feature selection problems: A medical case study. J Bionic Eng. 2024;21:409\u201325.","journal-title":"J Bionic Eng"},{"key":"6352_CR62","doi-asserted-by":"publisher","first-page":"37295","DOI":"10.1007\/s11042-023-16889-3","volume":"83","author":"I Obeidat","year":"2024","unstructured":"Obeidat I, Mughaid A, Alzu Bi S, Al-Arjan A, Al-Amrat R, Al-Ajmi R, et al. A novel secure cryptography model for data transmission based on Rotor64 technique. Multimed Tools Appl. 2024;83:37295\u2013314.","journal-title":"Multimed Tools Appl"},{"key":"6352_CR63","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1007\/s12652-022-03898-7","volume":"15","author":"L Abualigah","year":"2024","unstructured":"Abualigah L, Altalhi M. A novel generalized normal distribution arithmetic optimization algorithm for global optimization and data clustering problems. J Amb Intel Hum Comp. 2024;15:389\u2013417.","journal-title":"J Amb Intel Hum Comp"},{"key":"6352_CR64","doi-asserted-by":"publisher","first-page":"e70008","DOI":"10.1002\/hsr2.70008","volume":"7","author":"M Aghaei","year":"2024","unstructured":"Aghaei M, Khademi R, Bahreiny SS, Saki N. The need to Establish and recognize the field of clinical laboratory science (CLS) as an essential field in advancing clinical goals. Health Sci Rep. 2024;7:e70008.","journal-title":"Health Sci Rep"}],"container-title":["Journal of Translational Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12967-025-06352-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12967-025-06352-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12967-025-06352-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,19]],"date-time":"2025-03-19T11:07:54Z","timestamp":1742382474000},"score":1,"resource":{"primary":{"URL":"https:\/\/translational-medicine.biomedcentral.com\/articles\/10.1186\/s12967-025-06352-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3,19]]},"references-count":64,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["6352"],"URL":"https:\/\/doi.org\/10.1186\/s12967-025-06352-2","relation":{},"ISSN":["1479-5876"],"issn-type":[{"value":"1479-5876","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,3,19]]},"assertion":[{"value":"14 September 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 March 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 March 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Ethics approval and consent to participate approval of this study has been obtained at the Beijing University of Chinese Medicine\u2019s Ethics Committee.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}],"article-number":"349"}}